A detailed history of Legal & General Group PLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Legal & General Group PLC holds 1,508 shares of NPCE stock, worth $13,541. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,508
Previous 1,508 -0.0%
Holding current value
$13,541
Previous $10,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.38 - $15.33 $9,621 - $23,117
1,508 New
1,508 $11,000
Q2 2022

Aug 22, 2022

SELL
$4.95 - $8.7 $3,613 - $6,350
-730 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$19.03 - $26.5 $13,891 - $19,345
730 New
730 $17,000

Others Institutions Holding NPCE

About NeuroPace Inc


  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $223M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.